Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.88K Sell
17,826
-2,213
-11% -$208K 1.02% 24
2025
Q3
$1.68M Buy
20,039
+6,767
+51% +$557K 0.89% 44
2025
Q2
$1.05M Buy
13,272
+1,508
+13% +$120K 0.64% 64
2025
Q1
$1.06M Buy
11,764
+457
+4% +$42.7K 0.7% 52
2024
Q4
$1.12M Buy
11,307
+4,354
+63% +$449K 0.79% 48
2024
Q3
$790K Buy
6,953
+1,192
+21% +$142K 0.53% 62
2024
Q2
$713K Buy
5,761
+21
+0.4% +$2.71K 0.53% 59
2024
Q1
$757K Buy
5,740
+1,002
+21% +$124K 0.59% 43
2023
Q4
$517K Buy
+4,738
New +$492K 0.46% 55

Other funds holding MRK

Motiv8 Investments's MRK Position: Q4 2025 in Review

Motiv8 Investments reduced its Merck (MRK) stake by 11% in Q4 2025, selling an estimated $208K and leaving 17,826 shares worth $1.88K. The position accounts for 1.02% of the portfolio, ranked #24.

Motiv8 Investments first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.68M in Q3 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Motiv8 Investments held 17,826 shares of Merck worth $1.88K as of Q4 2025.
  • Motiv8 Investments sold 2,213 Merck shares in Q4 2025, an estimated $208K.
  • Merck made up 1.02% of Motiv8 Investments's portfolio in Q4 2025, its #24 holding.
  • Motiv8 Investments first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Motiv8 Investments's Merck position peaked at $1.68M in Q3 2025.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.